NEW YORK (Reuters Health) Dec 29 - Posaconazole is an effective alternative for patients with invasive aspergillosis refractory to conventional therapy, according to a report in the January 1, 2007 Clinical Infectious Diseases.
NEW YORK (Reuters Health) Dec 29 - Posaconazole is an effective alternative for patients with invasive aspergillosis refractory to conventional therapy, according to a report in the January 1, 2007 Clinical Infectious Diseases.
纽约（路透社健康专栏）12月29日—据《临床感染疾病》上2007年1月1日一篇文章称，泊沙康唑对传统药物难治的侵袭性曲霉菌病有效，可作为一种治疗选择。